查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1756457

综合代谢组 (CMP) 检测市场（按分析物、按疾病、按最终用途、按国家和地区）－2024 年至 2032 年的行业分析、市场规模、市场份额及预测

Comprehensive Metabolic Panel (CMP) Testing Market, By Analytes, By Disease, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 378 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年综合代谢组 (CMP) 测试市场规模价值 126.45 亿美元，从 2024 年到 2032 年的复合年增长率为 9.4%。

综合代谢组（CMP）检测市场-市场动态

预防性医疗保健需求不断增长

对预防性医疗保健的日益重视是综合代谢组 (CMP) 检测市场的主要驱动力。随着对早期诊断和疾病管理意识的不断提高，患者和医疗保健提供者都更加重视常规健康体检。 CMP 检测能够全面了解器官功能和代谢健康状况，正成为在症状出现前发现潜在健康问题的重要工具。此外，糖尿病、肾臟病和肝病等慢性疾病的盛行率不断上升，进一步刺激了需求。政府措施和预防性筛检的保险覆盖也促进了市场的扩张。

综合代谢组（CMP）检测市场－关键见解

根据我们的研究分析师，全球综合代谢组 (CMP) 测试市场预计在 2024 年至 2032 年期间的复合年增长率约为 9.4%。

2024 年按分析物细分，葡萄糖类别占据了市场主导地位。

根据疾病，糖尿病部门在 2024 年创造了最多的收入。

按地区划分，2024年北美是收入最高的地区。

综合代谢组（CMP）测试市场-細項分析：

全球综合代谢组 (CMP) 测试市场分为四类：分析物、疾病、最终用途和地区。

根据分析物，综合代谢组 (CMP) 检测市场细分为钾 (K+)、钠 (Na+)、氯 (Cl-)、二氧化碳 (CO2)、葡萄糖、血尿素氮 (BUN)、肌酸酐、钙 (Ca2+)、白蛋白、总蛋白、碱性磷酸酶 (ALP)、丙氨酸氨基转移酶 (ALT)、天冬氨酸转移酶 (ASTAST) 和总胆固醇。其中，由于全球糖尿病和糖尿病前期病例的增加，血糖检测占据了市场主导地位。及早发现异常血糖水平对于管理代谢紊乱和预防併发症至关重要。因此，葡萄糖分析通常包含在常规体检和疾病特异性筛检中。对即时检测和家庭监测的需求不断增长也有助于提高血糖检测的频率和可及性，进一步加强其在 CMP 分析物中的市场领导地位。

依疾病类型划分，综合代谢组 (CMP) 检测市场可细分为肾臟病、肝病、糖尿病及其他疾病。其中，糖尿病占据主导地位，这主要是因为其发生率普遍较高，且全球健康负担日益加重。 CMP 检测透过评估血糖水平和评估受疾病影响的器官功能（例如肾臟和肝臟），在糖尿病的诊断和监测中发挥关键作用。久坐不动的生活方式、不良的饮食习惯和人口老化导致第 2 型糖尿病发病率不断上升，这加剧了对常规代谢评估的需求。此外，倡导早期发现和预防保健的宣传活动和政府医疗保健计画进一步推动了糖尿病管理中对 CMP 检测的需求。

综合代谢组（CMP）检测市场-地理洞察

从地理分布来看，综合代谢组 (CMP) 检测市场分布于北美、亚太地区、拉丁美洲、欧洲、中东和非洲。这些地区根据业务来源国进一步划分。

北美凭藉其先进的医疗基础设施、高昂的医疗支出以及广泛采用的预防保健措施，在综合代谢组 (CMP) 检测市场占据主导地位。美国尤其如此，其糖尿病、肾臟病和肝病等慢性病的发生率很高。定期健康筛检和强大的保险覆盖进一步推动了 CMP 检测的需求。此外，领先的诊断实验室的存在以及公众对早期疾病检测意识的提高也发挥着至关重要的作用。医疗机构的策略性倡议和政府的优惠政策巩固了北美在全球 CMP 检测市场的领导地位。

受慢性病发病率上升和医疗保健意识增强的推动，亚太地区正成为中医（CMP）检测市场的关键成长区域。由于快速城镇化、生活方式的转变以及中产阶级人口的不断壮大，中国、印度和日本等国家对诊断检测的需求激增。该地区各国政府正在投资医疗基础设施并推广预防性保健计划，从而支持了市场的成长。此外，随着公立和私立医疗体系的扩张，诊断服务的可负担性和可近性也不断提高。这些因素共同使亚太地区成为中医检测最具潜力的市场之一。

综合代谢组（CMP）测试市场-竞争格局：

CMP 检测市场由雅培、Quest Diagnostics、美国实验室控股公司 (LabCorp) 和 Sonic Healthcare 等知名诊断公司主导。这些公司提供种类繁多、准确度高、可靠性高的代谢和生化检测产品。对研发和先进诊断技术的大力投入有助于维持合规性和产品创新。新进业者专注于整合人工智慧和即时检测，以提高诊断速度和可近性。这种竞争环境推动了检测效率、准确性和便利性的不断提升，支持 CMP 检测在全球临床和预防性医疗保健领域的更广泛应用。

最新动态：

2024 年 3 月，雅培推出了下一代即时血液分析仪，旨在进行快速代谢组检测，缩短远距医疗环境中的周转时间和提高可及性。

2025 年 1 月，Quest Diagnostics 在德州开设了一家最先进的检测设施，扩大了其实验室服务，提高了代谢和基因检测的能力，以满足不断增长的需求。

目录

第一章：综合代谢组（CMP）检测市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 综合代谢组 (CMP) 检测市场片段（分析者）
    • 综合代谢组 (CMP) 检测市场（按疾病）
    • 综合代谢组 (CMP) 检测市场片段（依最终用途）
    • 综合代谢组 (CMP) 检测市场（按国家/地区）
    • 综合代谢组 (CMP) 检测市场（按地区）
  • 竞争洞察

第三章：综合代谢组 (CMP) 检测关键市场趋势

  • 综合代谢组（CMP）检测市场驱动因素
    • 市场驱动因素的影响分析
  • 综合代谢组（CMP）检测市场限制
    • 市场限制的影响分析
  • 综合代谢组（CMP）检测市场机会
  • 综合代谢组（CMP）检测市场未来趋势

第四章：综合代谢组（CMP）检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：综合代谢组 (CMP) 检测市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长细分市场
    • 最鬆散的细分市场
    • 边际损失部分

第六章：综合代谢组 (CMP) 检测市场格局

  • 2023年综合代谢组（CMP）检测市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：综合代谢组 (CMP) 检测市场 - 按分析者

  • 概述
    • 细分市场占有率分析（按分析者）
    • 钾+
    • 钠离子
    • 氯离子
    • 二氧化碳
    • 葡萄糖
    • 包子
    • 肌酸酐
    • 钙离子
    • 白蛋白
    • 总蛋白
    • 碱性磷酸酶
    • 丙胺酸
    • AST
    • 总胆红素

第 8 章：综合代谢组 (CMP) 检测市场 - 按疾病

  • 概述
    • 按疾病细分的份额分析
    • 肾臟疾病
    • 肝臟疾病
    • 糖尿病
    • 其他的

第九章：综合代谢组 (CMP) 检测市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 实验室
      • 急诊室
      • 医院病房
      • 初级保健
      • 药局
      • 远距医疗
    • 概念验证
      • 急诊室
      • 医院病房
      • 初级保健
      • 药局
      • 远距医疗
    • PoC（工具）
      • Piccolo Xpress
      • Skyla-HB1
      • DRI-CHEM NX500
      • 其他的

第 10 章：综合代谢组 (CMP) 检测市场 - 按地理划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美综合代谢组 (CMP) 检测主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模与预测（分析师）
    • 北美市场规模及预测（按疾病）
    • 北美市场规模和预测，按最终用途
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲综合代谢组 (CMP) 检测主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（分析师）
    • 欧洲市场规模及预测（按疾病）
    • 欧洲市场规模和预测，按最终用途
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区综合代谢组 (CMP) 检测主要製造商
    • 亚太市场规模及预测（按国家/地区）
    • 亚太市场规模及预测（分析师）
    • 亚太市场规模及预测（按疾病）
    • 亚太市场规模及预测（依最终用途）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲综合代谢组 (CMP) 检测主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（分析师）
    • 拉丁美洲市场规模及预测（按疾病）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲综合代谢组 (CMP) 检测主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 分析师对中东和非洲市场规模和预测
    • 中东和非洲市场规模及预测（按疾病）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：主要供应商分析-综合代谢组 (CMP) 测试产业

  • 竞争仪錶板
  • 公司简介
    • Abbott
    • Quest Diagnostics
    • Laboratory Corporation of America Holdings Limited
    • Sonic Healthcare
    • Unipath
    • SYNLAB International GmbH
    • ARUP Laboratories
    • Genoptix Inc.
    • Nova Medical
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5325

REPORT HIGHLIGHT

Comprehensive Metabolic Panel (CMP) Testing Market size was valued at USD 12,645 Million in 2024, expanding at a CAGR of 9.4% from 2024 to 2032.

A Comprehensive Metabolic Panel (CMP) is a blood test that measures 14 different substances in the blood to provide information about the body's chemical balance and metabolism. It helps evaluate organ function, especially the liver and kidneys, and monitors conditions such as diabetes, liver disease, and electrolyte imbalances. The CMP includes tests for glucose, calcium, electrolytes (sodium, potassium, carbon dioxide, chloride), kidney function markers (BUN, creatinine), and liver enzymes (ALP, ALT, AST, bilirubin, albumin, total protein). Often part of routine health checkups, it aids in early detection and ongoing monitoring of various health conditions to support timely medical intervention.

Comprehensive Metabolic Panel (CMP) Testing Market- Market Dynamics

Growing Demand for Preventive Healthcare

The rising emphasis on preventive healthcare is a major driver of the Comprehensive Metabolic Panel (CMP) testing market. With increasing awareness about early diagnosis and disease management, both patients and healthcare providers are prioritizing routine health checkups. CMP tests, which offer a broad overview of organ function and metabolic health, are becoming essential tools for identifying potential health issues before symptoms appear. Additionally, the growing prevalence of chronic conditions such as diabetes, kidney disease, and liver disorders is further fueling demand. Government initiatives and insurance coverage for preventive screenings are also contributing to the market's expansion.

Comprehensive Metabolic Panel (CMP) Testing Market- Key Insights

According to our research analyst, the global Comprehensive Metabolic Panel (CMP) Testing Market is expected to develop at a CAGR of approximately 9.4% between 2024-2032.

Segmented by Analytes in 2024, the Glucose category dominated the market.

Based on Disease, the Diabetes segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Comprehensive Metabolic Panel (CMP) Testing Market- Segmentation Analysis:

The global Comprehensive Metabolic Panel (CMP) Testing Market is divided into Four categories: Analytes, Disease, End-use, and Region.

By analytes, the Comprehensive Metabolic Panel (CMP) testing market is segmented into potassium (K+), sodium (Na+), chloride (Cl-), carbon dioxide (CO2), glucose, blood urea nitrogen (BUN), creatinine, calcium (Ca2+), albumin, total protein, alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin. Among these, glucose testing dominates the market due to the global rise in diabetes and prediabetes cases. Early detection of abnormal blood sugar levels is critical in managing metabolic disorders and preventing complications. As a result, glucose analysis is commonly included in both routine checkups and disease-specific screenings. The increasing demand for point-of-care testing and home-based monitoring also contributes to the higher frequency and accessibility of glucose testing, further strengthening its market leadership within CMP analytes.

By disease, the Comprehensive Metabolic Panel (CMP) testing market is segmented into kidney diseases, liver diseases, diabetes, and others. Among these, diabetes is the dominant segment, primarily due to its widespread prevalence and the growing global health burden associated with the condition. CMP tests play a critical role in diagnosing and monitoring diabetes by evaluating blood glucose levels and assessing organ functions affected by the disease, such as the kidneys and liver. The increasing incidence of type 2 diabetes, driven by sedentary lifestyles, poor dietary habits, and aging populations, has heightened the need for routine metabolic assessments. Moreover, awareness campaigns and government healthcare programs promoting early detection and preventive care have further propelled the demand for CMP testing in diabetes management.

Comprehensive Metabolic Panel (CMP) Testing Market- Geographical Insights

Geographically, the Comprehensive Metabolic Panel (CMP) Testing Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America dominates the Comprehensive Metabolic Panel (CMP) testing market due to its advanced healthcare infrastructure, high healthcare spending, and widespread adoption of preventive care practices. The United States, in particular, contributes significantly with a high prevalence of chronic conditions such as diabetes, kidney disorders, and liver diseases. Regular health screening and strong insurance coverage further drive the demand for CMP tests. Additionally, the presence of leading diagnostic laboratories and increased public awareness about early disease detection play crucial roles. Strategic initiatives by healthcare providers and favorable government policies reinforce North America's leadership in the global CMP testing market.

Asia Pacific is emerging as a key growth region in the CMP testing market, driven by the rising incidence of chronic diseases and increasing healthcare awareness. Countries like China, India, and Japan are experiencing a surge in demand for diagnostic testing due to rapid urbanization, changing lifestyles, and expanding middle-class populations. Governments in the region are investing in healthcare infrastructure and promoting preventive health programs, which support market growth. Furthermore, the affordability and accessibility of diagnostic services are improving through both public and private healthcare expansions. These factors collectively position Asia Pacific as one of the most promising markets for CMP testing.

Comprehensive Metabolic Panel (CMP) Testing Market- Competitive Landscape:

The CMP testing market is dominated by established diagnostic firms such as Abbott, Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), and Sonic Healthcare. These companies offer a broad range of metabolic and biochemical tests with high accuracy and reliability. Heavy investments in R&D and advanced diagnostic technologies help maintain regulatory compliance and product innovation. New entrants focus on integrating AI and point-of-care testing to enhance diagnostic speed and accessibility. This competitive environment drives continuous advancements in testing efficiency, accuracy, and convenience, supporting wider adoption of CMP testing in clinical and preventive healthcare settings globally.

Recent Developments:

In March 2024, Abbott launched a next-generation point-of-care blood analyzer designed for rapid metabolic panel testing, improving turnaround time and accessibility in remote healthcare settings.

In January 2025, Quest Diagnostics expanded its laboratory services by opening a state-of-the-art testing facility in Texas, boosting capacity for metabolic and genetic testing to meet rising demand.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Quest Diagnostics
  • Laboratory Corporation of America Holdings Limited
  • Sonic Healthcare
  • Unipath
  • SYNLAB International GmbH
  • ARUP Laboratories
  • Genoptix Inc.
  • Nova Medical
  • Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY ANALYTES - MARKET ANALYSIS, 2019 - 2032

  • K+
  • Na+
  • Cl-
  • CO2
  • Glucose
  • BUN
  • Creatinine
  • Ca++
  • Albumin
  • Total Protein
  • ALP
  • ALT
  • AST
  • Total Bilirubin

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY DISEASE - MARKET ANALYSIS, 2019 - 2032

  • Kidney Diseases
  • Liver Diseases
  • Diabetes
  • Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

  • Laboratories
  • Emergency Departments
  • Hospital Wards
  • Primary Care
  • Pharmacy
  • Telemedicine
  • PoC
  • Emergency Departments
  • Hospital Wards
  • Primary Care
  • Pharmacy
  • Telemedicine
  • PoC (Instruments)
  • Piccolo Xpress
  • Skyla-HB1
  • DRI-CHEM NX500
  • Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Comprehensive Metabolic Panel (CMP) Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Analytes
    • 2.1.2. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Disease
    • 2.1.3. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by End Use
    • 2.1.4. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Country
    • 2.1.5. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Comprehensive Metabolic Panel (CMP) Testing Key Market Trends

  • 3.1. Comprehensive Metabolic Panel (CMP) Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Comprehensive Metabolic Panel (CMP) Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Comprehensive Metabolic Panel (CMP) Testing Market Opportunities
  • 3.4. Comprehensive Metabolic Panel (CMP) Testing Market Future Trends

4. Comprehensive Metabolic Panel (CMP) Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Comprehensive Metabolic Panel (CMP) Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Comprehensive Metabolic Panel (CMP) Testing Market Landscape

  • 6.1. Comprehensive Metabolic Panel (CMP) Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Comprehensive Metabolic Panel (CMP) Testing Market - By Analytes

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Analytes, 2023 & 2032 (%)
    • 7.1.2. K+
    • 7.1.3. Na+
    • 7.1.4. Cl-
    • 7.1.5. CO2
    • 7.1.6. Glucose
    • 7.1.7. BUN
    • 7.1.8. Creatinine
    • 7.1.9. Ca++
    • 7.1.10. Albumin
    • 7.1.11. Total Protein
    • 7.1.12. ALP
    • 7.1.13. ALT
    • 7.1.14. AST
    • 7.1.15. Total Bilirubin

8. Comprehensive Metabolic Panel (CMP) Testing Market - By Disease

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 8.1.2. Kidney Diseases
    • 8.1.3. Liver Diseases
    • 8.1.4. Diabetes
    • 8.1.5. Others

9. Comprehensive Metabolic Panel (CMP) Testing Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 9.1.2. Laboratories
      • 9.1.2.1. Emergency Departments
      • 9.1.2.2. Hospital Wards
      • 9.1.2.3. Primary Care
      • 9.1.2.4. Pharmacy
      • 9.1.2.5. Telemedicine
    • 9.1.3. PoC
      • 9.1.3.1. Emergency Departments
      • 9.1.3.2. Hospital Wards
      • 9.1.3.3. Primary Care
      • 9.1.3.4. Pharmacy
      • 9.1.3.5. Telemedicine
    • 9.1.4. PoC (Instruments)
      • 9.1.4.1. Piccolo Xpress
      • 9.1.4.2. Skyla-HB1
      • 9.1.4.3. DRI-CHEM NX500
      • 9.1.4.4. Others

10. Comprehensive Metabolic Panel (CMP) Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Comprehensive Metabolic Panel (CMP) Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott
    • 11.2.2. Quest Diagnostics
    • 11.2.3. Laboratory Corporation of America Holdings Limited
    • 11.2.4. Sonic Healthcare
    • 11.2.5. Unipath
    • 11.2.6. SYNLAB International GmbH
    • 11.2.7. ARUP Laboratories
    • 11.2.8. Genoptix Inc.
    • 11.2.9. Nova Medical
    • 11.2.10. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us